Matrix Laboratories NV, a Belgian Ltd corporation controlled by the Matrix Laboratories Ltd, acquired 4,644,512 shares in Docpharma as a result of the public take-over bid which closed on September 28, 2005, thereby raising its shareholding up to 95.51%. Payment of the offer price of EUR 34.00 per share will occur on October 13, 2005.

According to the company release, in accordance with article 513 of the Belgian Companies Code, Matrix Laboratories NV will bring a public squeeze-out bid for all remaining Docpharma shares which were not tendered. The squeeze-out bid runs from October 12, 2005 till November 02, 2005 (including), and is made on the same terms, i.e. EUR 34.00 per Docpharma share, coupon no. 1 and the following attached.

After expiry of the public squeeze-out bid, the shares, which have not been tendered, will be deemed to have been transferred to Matrix Laboratories NV, with consignation of the offer price. At the date of closing of the Squeeze-out Bid (November 02, 2005), after close of trading, the Docpharma shares will be de-listed from Euronext Brussels, added the release.